American Century Companies’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$660K Sell
139,878
-138,913
-50% -$656K ﹤0.01% 2438
2025
Q1
$1.28M Sell
278,791
-21,485
-7% -$98.6K ﹤0.01% 2166
2024
Q4
$1.44M Buy
300,276
+6,079
+2% +$29.1K ﹤0.01% 2130
2024
Q3
$1.38M Buy
294,197
+24,226
+9% +$114K ﹤0.01% 2122
2024
Q2
$1.53M Buy
269,971
+18,733
+7% +$106K ﹤0.01% 2000
2024
Q1
$1.03M Buy
251,238
+18,743
+8% +$77K ﹤0.01% 2137
2023
Q4
$981K Buy
232,495
+15,549
+7% +$65.6K ﹤0.01% 2074
2023
Q3
$937K Buy
216,946
+135,022
+165% +$583K ﹤0.01% 2014
2023
Q2
$540K Buy
81,924
+62,458
+321% +$412K ﹤0.01% 2185
2023
Q1
$131K Sell
19,466
-26,247
-57% -$176K ﹤0.01% 2502
2022
Q4
$338K Buy
45,713
+7,000
+18% +$51.7K ﹤0.01% 2179
2022
Q3
$382K Buy
+38,713
New +$382K ﹤0.01% 2050
2022
Q2
Sell
-55,245
Closed -$625K 2388
2022
Q1
$625K Buy
55,245
+141
+0.3% +$1.6K ﹤0.01% 1863
2021
Q4
$865K Hold
55,104
﹤0.01% 1712
2021
Q3
$944K Buy
55,104
+761
+1% +$13K ﹤0.01% 1619
2021
Q2
$1.17M Hold
54,343
﹤0.01% 1481
2021
Q1
$816K Buy
54,343
+1,565
+3% +$23.5K ﹤0.01% 1527
2020
Q4
$694K Sell
52,778
-30,474
-37% -$401K ﹤0.01% 1415
2020
Q3
$804K Buy
83,252
+11,301
+16% +$109K ﹤0.01% 1178
2020
Q2
$823K Sell
71,951
-26,311
-27% -$301K ﹤0.01% 1141
2020
Q1
$1.02M Buy
98,262
+21,136
+27% +$219K ﹤0.01% 983
2019
Q4
$1.27M Sell
77,126
-133,414
-63% -$2.19M ﹤0.01% 1056
2019
Q3
$2.8M Buy
+210,540
New +$2.8M ﹤0.01% 917
2019
Q2
Sell
-113,208
Closed -$2.08M 1351
2019
Q1
$2.08M Buy
113,208
+1,103
+1% +$20.3K ﹤0.01% 985
2018
Q4
$2.93M Sell
112,105
-43,326
-28% -$1.13M ﹤0.01% 909
2018
Q3
$3.57M Buy
155,431
+95,325
+159% +$2.19M ﹤0.01% 923
2018
Q2
$1.15M Buy
+60,106
New +$1.15M ﹤0.01% 1087
2016
Q4
Sell
-92,700
Closed -$1.54M 1415
2016
Q3
$1.54M Buy
+92,700
New +$1.54M ﹤0.01% 1099